Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study (COGMA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04421690
Recruitment Status : Recruiting
First Posted : June 9, 2020
Last Update Posted : November 2, 2020
Sponsor:
Information provided by (Responsible Party):
Ashley Curtis, University of Missouri-Columbia

Brief Summary:
The purpose of this research is to look at the effects of computerized cognitive training on anxiety, sleep, mental abilities (cognition), and other aspects of daytime functioning, such as arousal.

Condition or disease Intervention/treatment Phase
Generalized Anxiety Disorder Behavioral: Cognitive Training Behavioral: Trivia Training Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Participants will be randomly assigned to cognitive training or trivia training and will complete measures of anxiety, sleep, cognition (objective, self-efficacy), and self-reported arousal at baseline, and post-intervention
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study (COGMA)
Actual Study Start Date : June 8, 2020
Estimated Primary Completion Date : May 31, 2021
Estimated Study Completion Date : May 31, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
Experimental: Cognitive Training
8 week computerized cognitive training
Behavioral: Cognitive Training
Participants (n=15) will complete computerized cognitive training games and activities online 3 times/week for 8 weeks.

Active Comparator: Trivia Training
8 week computerized trivia training
Behavioral: Trivia Training
Participants (n=15) will receive computerized trivia questions to answer and submit 3 times/week for 8 weeks.




Primary Outcome Measures :
  1. Objective Cognition - Computerized Cognitive Tasks [ Time Frame: Up to 10 weeks ]
    Complete computerized tasks. These tasks will measure cognitive functions (e.g., processing speed).

  2. Objective Cognition - Computerized Cognitive Tasks [ Time Frame: Up to 10 weeks ]
    Complete computerized tasks. These tasks will measure cognitive functions (e.g., attention).

  3. Objective Cognition - Computerized Cognitive Tasks [ Time Frame: Up to 10 weeks ]
    Complete computerized tasks. These tasks will measure cognitive functions (e.g., executive function).

  4. Subjective Cognitive Self-Efficacy. -Cognitive Failures Questionnaire [ Time Frame: Up to 10 weeks ]
    A 25-item questionnaire. Participants rate from 0 (never) to 4 (very often) frequency of cognitive errors. Higher scores indicate lower cognitive self-efficacy.

  5. Coronavirus Anxiety Scale [ Time Frame: Up to 10 weeks ]
    5- item questionnaire that assess anxiety related to the Coronavirus.

  6. Anxiety - State-Trait Anxiety Inventory [ Time Frame: Up to 10 weeks ]
    Inventory that asks respondents to rate how true 20 self-descriptive statements (e.g., I feel calm) are on a 4-point scale (1 = not at all, 4 = very much so). Typically, respondents are asked to rate statements according to how they generally feel (trait-anxiety scale) and how they feel in the current moment (state-anxiety scale). Total scores range from 20 to 80, with higher scores indicating greater maladjustment.


Secondary Outcome Measures :
  1. Game-related experience- Sessions and duration played [ Time Frame: Up to 10 weeks ]
    During the intervention phase the cognitive training group will play games and will need to log the days and duration played.

  2. Circadian Rhythm- Morningness-Eveningness Questionnaire [ Time Frame: Up to 10 weeks ]
    19-item questionnaire that assesses preference for morning, afternoon, and evening activities. Total score reflects degree of "morningness" or "eveningness" type.

  3. Subjective Arousal- Global Cognitive Arousal-Perceived Stress Scale [ Time Frame: Up to 10 weeks ]
    Perceived Stress Scale is a self-report measure of how life situations are perceived as stressful. The scale consists of 15 items corresponding to everyday situation and participants are asked to rate on a likert scale from 0 (never) to 4 (very often) how often they felt or thought a specific way. Higher scores correspond to higher perceived stress.

  4. Subjective Arousal- Pre-sleep Arousal Scale [ Time Frame: Up to 10 weeks ]
    Pre-sleep Arousal Scale is a 16-item self-report questionnaire comprising both cognitive and somatic manifestations of arousal.

  5. Subjective Arousal- Arousal Predisposition Scale Subjective Arousal- Arousal Predisposition Scale Subjective Arousal- Arousal Predisposition Scale [ Time Frame: Up to 10 weeks ]
    Arousal Predisposition Scale is a 12-item inventory that has been designed to measure the degree to which an individual experiences arousal. Higher scores indicate greater predisposition to arousal.

  6. Game Engagement Questionnaire [ Time Frame: Up to 10 weeks ]
    Questionnaire assessing the experience of the game.

  7. Mood-Depression-Beck Depression Inventory-II [ Time Frame: Up to 10 weeks ]
    21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations. Higher total scores indicate worse depressive symptoms.

  8. Alcohol Use - Alcohol Use Disorder Test [ Time Frame: Baseline ]
    10-item questionnaire that assess the frequency of alcohol use and problems associated with alcohol use over the past year.

  9. Physical Activity - International Physical Activity Questionnaire [ Time Frame: Up to 10 weeks ]
    7- item questionnaire assessing the different kinds of physical activities that the participant does as pat of their everyday life.

  10. Personality - Big Five Inventory [ Time Frame: Baseline ]
    10 question assessment measuring personality.

  11. COVID-19 related media exposure and risk questions [ Time Frame: Up to 10 weeks ]
    20- item questionnaire assessing the effects of news and social media on perception of COVID-19.

  12. Subjective Intervention Efficacy- Internet Intervention Utility Questionnaire [ Time Frame: Up to 10 weeks ]
    16- item questionnaire about the use of the intervention.

  13. Computer Proficiency- Computer Proficiency Questionnaire [ Time Frame: Baseline ]
    This questionnaire asks about participants' ability to perform a number of tasks with a computer. Will be examined as a covariate.

  14. Subjective Behavioral Sleep- Insomnia Severity Index [ Time Frame: Up to 10 weeks ]
    Brief self-report measure of current perception of insomnia symptom severity, distress and daytime impairment. Commonly used in insomnia treatment outcome research.

  15. Beck Depression Inventory-2nd Edition [ Time Frame: Up to 10 weeks ]
    21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations. Higher total scores indicate worse depressive symptoms.

  16. Subjective Behavioral Sleep - Electronic Daily Sleep Diaries [ Time Frame: Up to 10 weeks ]
    Online diaries completed each morning (~5 mins); diaries measure sleep onset latency, wake time after sleep onset, total sleep time, and sleep quality.

  17. Subjective Behavioral Sleep - Electronic Daily Sleep Diaries [ Time Frame: Up to 10 weeks ]
    Online diaries completed each morning (~5 mins); diaries measure sleep onset latency

  18. Subjective Behavioral Sleep - Electronic Daily Sleep Diaries [ Time Frame: Up to 10 weeks ]
    Online diaries completed each morning (~5 mins); diaries measure wake time after sleep onset

  19. Subjective Behavioral Sleep - Electronic Daily Sleep Diaries [ Time Frame: Up to 10 weeks ]
    Online diaries completed each morning (~5 mins); diaries measure total sleep time

  20. Subjective Behavioral Sleep - Electronic Daily Sleep Diaries [ Time Frame: Up to 10 weeks ]
    Online diaries completed each morning (~5 mins); diaries measure sleep quality



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   45 Years to 59 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 45-59 yrs of age
  • no neurological or psychiatric illness, dementia, or loss of consciousness > 5 mins
  • nongamers (i.e., report <1 hour of video/cognitive training games/week over last 2 yrs)
  • proficient in English (reading and writing)
  • computer meets technology requirements (i.e. Windows: Windows 7 or above using Internet Explorer 11 or Edge, Mozilla Firefox 41 and above, Google Chrome 48 and above; Mac OS: Mac OS X v10.8 and above using Safari 10 and above, Mozilla Firefox 42 and above, Google Chrome 48 and above; Android App: Android 6 or higher version; iOS App: iOS 10 or higher version
  • meet clinical dx criteria for Generalized Anxiety Disorder.

Exclusion Criteria:

  • unable to provide informed consent
  • unable to undergo randomization
  • Telephone Interview for Cognitive Status-modified (TICS) score <33, 2)
  • other sleep disorder (i.e., sleep apnea, Periodic Limb Movement Disorder-PLMD, narcolepsy, REM Sleep Behavior Disorder)
  • severe untreated psychiatric comorbidity that renders randomization unethical
  • psychotropic, anxiolytic medications or other medications(e.g., beta-blockers) that alter mood or sleep
  • uncorrected visual/auditory impairments
  • participation in nonpharmacological treatment for sleep/fatigue/mood outside the current study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04421690


Contacts
Layout table for location contacts
Contact: Jacob Wilhelm 573-884-3293 cashlab@health.missouri.edu

Locations
Layout table for location information
United States, Missouri
University of Missouri Recruiting
Columbia, Missouri, United States, 65201
Contact: Ashley Curtis, PhD         
Principal Investigator: Ashley Curtis, PhD         
Sponsors and Collaborators
University of Missouri-Columbia
Investigators
Layout table for investigator information
Principal Investigator: Ashley Curtis, PhD University of Missouri- School of Medicine
Layout table for additonal information
Responsible Party: Ashley Curtis, Assistant Professor, University of Missouri-Columbia
ClinicalTrials.gov Identifier: NCT04421690    
Other Study ID Numbers: 2021943
First Posted: June 9, 2020    Key Record Dates
Last Update Posted: November 2, 2020
Last Verified: October 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Ashley Curtis, University of Missouri-Columbia:
Anxiety
Middle-Aged
Sleep
Cognition
Older Adults
Additional relevant MeSH terms:
Layout table for MeSH terms
Anxiety Disorders
Mental Disorders